Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats
- 11 January 2021
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 53 (8) , 2835-2847
Abstract
Pedunculopontine nucleus (PPN) cholinergic neurons are implicated in freezing of gait in Parkinson's disease (PD) and motor stereotypy in normal animals, but the causal role of these neurons on specific gait parameters and treatment‐induced dyskinesia remains speculative. Therefore, we examined whether selective cholinergic lesion of the rostral PPN affects PD motor and gait deficits, L‐DOPA‐induced dyskinesia and motor improvement, and DA‐agonist‐induced dyskinesia. Sprague–Dawley rats were assigned to one unilaterally lesioned group: Sham lesion, PPN cholinergic lesion with diphtheria urotensin II fusion toxin, medial forebrain bundle dopamine lesion with 6‐hydroxydopamine, or dual acetylcholine and dopamine lesion. We used gait analysis and forepaw adjusting steps to examine PD gait and motor deficits. Forepaw adjusting steps were also used to assess motor improvement with L‐DOPA treatment. The abnormal involuntary movements scale measured L‐DOPA and dopamine D1‐ and D2‐receptor agonist‐induced dyskinesia. Lesions, verified via tyrosine hydroxylase and choline acetyltransferase immunohistochemistry reduced an average of 95% of nigral dopamine neurons and 80% of PPN cholinergic neurons, respectively. Rats receiving acetylcholine and dual lesion demonstrated enhanced freezing, and acetylcholine lesioned rats exhibited increased print area and stand index. Dopamine and dual lesion produced similar forepaw adjusting steps task on and off L‐DOPA. Relative to DA lesioned rats, dual lesioned rats displayed reduced L‐DOPA and DA agonist‐induced dyskinesia at specific time points. Our results indicate that PPN cholinergic neurons affect gait parameters related to postural stability. Therefore, therapeutically targeting PPN cholinergic neurons could reduce intractable postural instability in PD without affecting motor benefits or side effects of L‐DOPA treatment.Keywords
Funding Information
- American Parkinson Disease Association
This publication has 43 references indexed in Scilit:
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal of Clinical Investigation, 2010
- History of falls in Parkinson disease is associated with reduced cholinergic activityNeurology, 2009
- Assessment of weight bearing changes and pharmacological antinociception in mice with LPS-induced monoarthritis using the Catwalk gait analysis systemLife Sciences, 2009
- Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: Effects of morphine and rofecoxibJournal of Neuroscience Methods, 2008
- The pedunculopontine nucleus in Parkinson's disease: primate studiesBritish Journal Of Neurosurgery, 2008
- Evaluation of Levodopa Dose and Magnitude of Dopamine Depletion as Risk Factors for Levodopa-Induced Dyskinesia in a Rat Model of Parkinson’s DiseaseThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson’s diseaseNeurobiology of Disease, 2007
- Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's diseaseBrain, 2007
- A robust automated method to analyze rodent motion during fear conditioningNeuropharmacology, 2007
- The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988